Broadfin Capital’s St Jude Medical STJ Stock Holding History

Broadfin Capital’s Portfolio STJ Stock Details STJ Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q1	–	Sell	-200,000	Closed	-$12.4M	–	91
2015 Q4	$12.4M	Buy	+200,000	New	+$12.6M	0.76%	35
2014 Q1	–	Sell	-100	Closed	-$6K	–	93
2013 Q4	$6K	Buy	+100	New	+$5.79K	﹤0.01%	60

Other funds holding STJ

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Sanders Capital West Palm Beach, Florida $83.9B AUM 37.89% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Boston Partners Boston, Massachusetts $95.5B AUM 28.4% 1-Year Est. Return

Broadfin Capital's STJ Position: Q1 2016 in Review

Broadfin Capital sold out of St Jude Medical (STJ) in Q1 2016, closing a stake of 200,000 shares — an estimated $12.4M sold.

Broadfin Capital first reported a position in STJ in Q4 2013 and held it in 2 quarters. The position peaked at $12.4M in Q4 2015. 570 funds tracked by Wall St. Rank hold STJ as of Q1 2016.

Broadfin Capital reported no remaining St Jude Medical position as of Q1 2016 after selling out during the quarter.
Broadfin Capital sold 200,000 St Jude Medical shares in Q1 2016, an estimated $12.4M.
Broadfin Capital first reported a position in St Jude Medical in Q4 2013 and held it in 2 quarters.
Broadfin Capital's St Jude Medical position peaked at $12.4M in Q4 2015.
570 funds tracked by Wall St. Rank held St Jude Medical as of Q1 2016.

Based on Broadfin Capital's 13F filing for Q1 2016, filed 16 May 2016.